Search

Your search keyword '"Arroyo V."' showing total 277 results

Search Constraints

Start Over You searched for: Author "Arroyo V." Remove constraint Author: "Arroyo V." Topic liver cirrhosis Remove constraint Topic: liver cirrhosis
277 results on '"Arroyo V."'

Search Results

1. A robust clustering strategy for stratification unveils unique patient subgroups in acutely decompensated cirrhosis.

2. Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis.

3. New clinical and pathophysiological perspectives defining the trajectory of cirrhosis.

4. Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF).

5. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis.

6. The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis.

7. Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF.

8. Albumin protects the liver from tumor necrosis factor α-induced immunopathology.

9. Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation.

10. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.

11. Albumin in decompensated cirrhosis: new concepts and perspectives.

12. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF.

13. Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis.

14. Orchestration of Tryptophan-Kynurenine Pathway, Acute Decompensation, and Acute-on-Chronic Liver Failure in Cirrhosis.

16. Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt.

17. Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis.

18. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.

19. Oxidized Albumin Triggers a Cytokine Storm in Leukocytes Through P38 Mitogen-Activated Protein Kinase: Role in Systemic Inflammation in Decompensated Cirrhosis.

20. Acute-on-Chronic Liver Failure: Getting Ready for Prime Time?

21. The use of human albumin in patients with cirrhosis: a European survey.

22. Cell death markers in patients with cirrhosis and acute decompensation.

23. Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis.

24. Short article: Impact of genetic variation in the vasopressin 1a receptor on the development of organ failure in patients admitted for acute decompensation of liver cirrhosis.

25. Microalbuminuria, systemic inflammation, and multiorgan dysfunction in decompensated cirrhosis: evidence for a nonfunctional mechanism of hepatorenal syndrome.

26. Clinical course and short-term mortality of cirrhotic patients with infections other than spontaneous bacterial peritonitis.

27. Diagnosis and prognosis of acute on chronic liver failure (ACLF) in cirrhosis.

28. Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure.

29. Acute-on-chronic liver failure in cirrhosis.

30. Role of albumin in diseases associated with severe systemic inflammation: Pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosis.

31. Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B.

32. Kinase analysis in alcoholic hepatitis identifies p90RSK as a potential mediator of liver fibrogenesis.

33. Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF).

34. Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis.

35. Severe acute kidney injury associated with non-steroidal anti-inflammatory drugs in cirrhosis: A case-control study.

36. Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis.

37. The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure.

38. Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis.

39. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites.

40. Human serum albumin, systemic inflammation, and cirrhosis.

41. Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections.

42. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013.

43. Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival.

44. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).

45. Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells.

46. Relative adrenal insufficiency in decompensated cirrhosis: Relationship to short-term risk of severe sepsis, hepatorenal syndrome, and death.

47. Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications.

49. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.

Catalog

Books, media, physical & digital resources